Lipogenic Neoplasms
Lipogenic neoplasms, tumors arising from fat tissue, are the most common group of growths in the soft tissues and under the skin. They range from entirely benign lesions (such as conventional lipoma, pleomorphic lipoma and angiolipoma) to malignant tumors that invade locally and metastasize aggressively (liposarcoma). Abnormal accumulations of neoplastic fat cells (adipocytes) can develop anywhere in the body, with the subcutaneous fat being the most common site.
The biggest clinical challenge for dermatologists and soft tissue surgeons is telling a large benign lipoma or an atypical lipomatous tumor (ALT) apart from a well-differentiated liposarcoma. A wrong diagnosis can lead to surgery without adequate safety margins, resulting in stubborn recurrences or serious malignant progression.
At Haute-Derma, we follow a standardized pathway that combines high-frequency Doppler ultrasound or soft tissue MRI, histopathology, immunohistochemistry (IHC) and genetic testing for MDM2 amplification, so we can make an accurate differential diagnosis and plan the best surgical and cosmetic strategy.
Our Approach to Treating Fatty Tissue Tumors
Haute-Derma manages fatty tumors using a standardized medical and aesthetic strategy:
- Size and Depth Screening: The "5 cm Rule": Any fatty lump under the skin larger than 5 cm, lying beneath the muscle fascia (subfascial), or growing quickly must have an MRI and a biopsy tested for MDM2 to rule out ALT/liposarcoma before surgery.
- Finding the Cause of Pain: We identify angiolipomas early in patients with multiple painful nodules under the skin so they can be fully removed.
- Minor Surgery With Capsular Enucleation: The whole lipoma is removed together with its thin fibrous capsule to minimize the risk of local recurrence.
- Cosmetic Incision Planning and Scar Reduction: For cosmetically sensitive areas such as the face, neck and forearms, we use a minimal-incision technique or endoscopic/microsurgical dissection.
How Fatty Tumors Are Diagnosed at Haute-Derma
To draw a clear line between benign tumors and fat cancers, Haute-Derma follows a 4-step process:
- Clinical Examination of the Soft Tissue: We assess consistency (soft, firm or lumpy), borders, mobility relative to the deep fascia, and tenderness.
- High-Frequency Doppler Ultrasound / Soft Tissue MRI:
- Ultrasound: evaluates the capsule, blood vessel growth and echo pattern (hyperechoic/hypoechoic).
- MRI: the gold standard for tumors larger than 5 cm, showing thick infiltrating fibrous septa (a warning sign for ALT/WDLPS).
- Core Needle or Incisional Biopsy: Required when the tumor is deep, large or looks suspicious on MRI.
- Histopathology, IHC and Genetic Testing (MDM2 FISH): A panel of S100, CD34, MDM2 and CDK4 stains is performed, and fluorescence in situ hybridization (FISH) looks for MDM2 gene amplification to confirm a diagnosis of atypical lipomatous tumor (ALT).
Specialist Treatment at Haute-Derma
Treatment is tailored to the tumor's histological type and anatomical location:
- Treating Benign Fatty Tumors (Lipoma / Angiolipoma / Spindle Cell Lipoma):
- Minor Surgical Removal With the Capsule (Enucleation / Excision): The most definitive treatment. The doctor makes a small incision only one-third to one-half the size of the tumor, shells out the entire lipoma with its capsule, and closes the wound in several cosmetic layers.
- Liposuction-Assisted Excision: Used for very large benign lipomas on the back or thighs, or for widespread multiple lipomas, to avoid long surgical scars, although recurrence is slightly more common because the capsule is hard to remove completely.
- Fat-Dissolving Injections (Intralesional Deoxycholate / Steroid): An alternative for small, localized lipomas in areas that are difficult to operate on.
- Treating Atypical Lipomatous Tumor (ALT) and Liposarcoma:
- Wide Local Excision (WLE) With Clear Microscopic Margins: The tumor is removed with a margin of at least 1.0–2.0 cm of healthy tissue, along with the underlying deep fascia, to achieve negative (R0) margins.
- Together with oncologists, we arrange adjuvant radiotherapy (before or after surgery) and systemic chemotherapy for myxoid or pleomorphic liposarcomas with a high risk of spread.